Comment
doi: 10.1016/S1473-3099(21)00198-5.
Adjunctive clindamycin therapy in invasive β-haemolytic streptococcal infections
Affiliations
- PMID: 34051183
- DOI: 10.1016/S1473-3099(21)00198-5
Item in Clipboard
Comment
Adjunctive clindamycin therapy in invasive β-haemolytic streptococcal infections
Lancet Infect Dis.
2021 Jun.
No abstract available
Conflict of interest statement
We declare no competing interests.
Comment in
-
Adjunctive clindamycin therapy in invasive β-haemolytic streptococcal infections - Authors' reply.Lancet Infect Dis. 2021 Jun;21(6):762-763. doi: 10.1016/S1473-3099(21)00259-0. Lancet Infect Dis. 2021. PMID: 34051182 No abstract available.
Comment on
-
Effectiveness of adjunctive clindamycin in β-lactam antibiotic-treated patients with invasive β-haemolytic streptococcal infections in US hospitals: a retrospective multicentre cohort study.Lancet Infect Dis. 2021 May;21(5):697-710. doi: 10.1016/S1473-3099(20)30523-5. Epub 2020 Dec 14. Lancet Infect Dis. 2021. PMID: 33333013 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
